Crossmark

The clinical utility of proton magnetic resonance spectroscopy in traumatic brain injury: recommendations from the ENIGMA MRS working group

Published Online: 2020-08-14

Published Print: 2021-04

Authors

Bartnik-Olson, Brenda L https://orcid.org/0000-0002-1137-9437
Alger, Jeffry R

Babikian, Talin

Harris, Ashley D

Holshouser, Barbara

Kirov, Ivan I

Maudsley, Andrew A

Thompson, Paul M

Dennis, Emily L

Tate, David F

Wilde, Elisabeth A

Lin, Alexander
Funding

Funding for this research was provided by:

National Institutes of Health (K99NS096116, R21NS112853, R01EB016064, U54EB020403, R01MH116147, R56AG058854, R01MH111671, R01HD061504, R01HD061504, R01HD061504)

National Institutes of Health (R01NS097494)

National Institutes of Health (P41EB017183, P30AG008051, P41EB015922)
License Information

Text and Data Mining valid from 2020-08-14

Version of Record valid from 2020-08-14
More Information

Article History

First Online: 14 August 2020

Compliance with ethical standards

:

: Dr. Alger is the owner of NeuroSpectroScopics LLC. Dr. Lin is the co-founder of BrainSpec and a consultant for Moncton MRI. Dr. Thompson received partial research support from Biogen, Inc. for research unrelated to this manuscript.

Document is current